K984569 · Ab2 Medical Products, Llp · FPA · Aug 12, 1999 · General Hospital
Device Facts
Record ID
K984569
Device Name
AB2 MED-FLO SOLUTION SET
Applicant
Ab2 Medical Products, Llp
Product Code
FPA · General Hospital
Decision Date
Aug 12, 1999
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.5440
Device Class
Class 2
Attributes
Therapeutic
Indications for Use
The AB2 Med-Flo Solution Set is intended to be used to provide a sterile pathway from the solution source (I.V.bag) to the patient's intravascular catheter. The flow of the solution is accomplished by gravity flow.
Device Story
AB2 Med-Flo Solution Set provides sterile fluid pathway between I.V. bag and patient intravascular catheter. Operates via gravity flow; no active components. Used in clinical settings by healthcare professionals to facilitate fluid delivery. Device ensures sterile connection; maintains fluid path integrity during administration. Benefits patient by enabling controlled, sterile intravenous therapy.
Clinical Evidence
Bench testing only.
Technological Characteristics
Sterile, gravity-fed intravenous administration set. Consists of tubing and connectors designed to maintain a sterile fluid pathway from I.V. bag to catheter. No electronic components, software, or active energy sources.
Indications for Use
Indicated for patients requiring intravenous fluid administration via a sterile pathway from an I.V. bag to an intravascular catheter using gravity flow.
Regulatory Classification
Identification
An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.
Special Controls
*Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
Related Devices
K191640 — TK Intravascular Administration Set · Anhui Tiankang Medical Technology Co., Ltd. · Aug 26, 2020
K052658 — SELECTFLOW - INTRAVASCULAR ADMINISTRATION SET · Renascence Medical, Inc. · Oct 12, 2005
K042693 — IV ADMINISTRATION SET B400 SP · Codan US Corp. · Oct 21, 2004
K992266 — IV ADMINISTRATION SET · New Alliance of Independent Medical Distributors, · Oct 27, 1999
K162951 — TUBETECH IV Administration Set · Douglas Medical Products, Inc. · Jul 28, 2017
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol of three abstract human figures, represented by flowing lines, suggesting unity and collaboration.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 12 1999
Mr. Arthur Chandler, III AB2 Medical Products, L.L.P. 52 Buttonbush Court The Woodlands, Texas 77380
K984569 Re: AB2 Med-Flo Solution Set Trade Name: Regulatory Class: II Product Code: FPA May 10, 1999 Dated: Received: May 19, 1999
Dear Mr. Chandler:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). *You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obliqation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
{1}------------------------------------------------
Page 2 - Mr. Chandler
This letter will allow you to begin marketing your device as Inis lecter will arrow you owns to notification. The FDA finding described in your siew. I pour device to a legally marketed of Subscantial equivalor a classification for your device and produce are arrants your device to the market. chus, Delmics your device for your device on our labeling II you desire bpcorre and additionally 809.10 for in vitro reguration (ar c.n), please contact the Office of Compliance at Glaghobere actrocery promally, for questions on the promotion and (501) 594 1092. Thanksvice, please contact the Office of advertibing or your acticle , Also, please note the regulation Compriance at (301) 371 1039 - 1059 - 10 premarket notification" (21 Other general information on your responsibilities CFR 807.97). under the Act may be obtained from the Division of Small under the Act may be obsainsits toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A. Ulatowski
Timot Director
Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radioloqical Health
Enclosure
{2}------------------------------------------------
K984569
510(k) Number: K984569 Devicc Name: AB2 Mcd-110 Solution Sct
## Indications l'or Use:
The AU2 Med-I'lo Solution Sct is intended to be used to provide a sterile pathway from the solution source (T.V.bag) to the patient's intravascular catheter. The flow of the solution is accomplisched i by gravity flow.
(Division Sign-Off) Monde lle
Division of Dental, Infection Control,
and General Hospital Devices
510(k) Number. 1984567
Prescription Use (Per 21 CFR 801.109)
510(k) Number: K984569
Panel 1
/
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.